UCB Switzerland News and Activities

UCB Switzerland is owned by UCB.

UCB is one of the...

• Forbes Global 2000 (#1031);
• Stoxx 600;
• TOB Iconic 10,000.

UCB is a company listed under the stock ticker UCB (BE).

UCB has a direct presence in 9 countries.

UCB has 9 subsidiaries including UCB Australia, UCB Canada and UCB France.

They are in:

• Pharmaceuticals90%
• Fund10%

Acquisition, funding and merger involving UCB.

• UCB has announced the acquisition of Candid Therapeutics  (posted on May 5 2026).
• UCB has announced the acquisition of Neurona Therapeutics  (posted on April 20 2026).

View the org chart displaying its 5 main executives

Most searched biographies at UCB Switzerland

• Anne Bernier, Head, Manufacturing Procurement
• Damien Rime, Head, Information Technology Industrial Techologies
• Helton Freimuller, Head, Finance And Administration

Create your alert
to follow the executive moves at UCB Switzerland.

UCB has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by UCB Switzerland

Social media about UCB Switzerland

• UCB Switzerland on Wikipedia, Google News & Yahoo Finance
• UCB Switzerland on LinkedIn, X (Twitter) & YouTube